Vertex Pharmaceuticals (VRTX) EV to EBITDA (2011 - 2026)
Vertex Pharmaceuticals' (VRTX) EV to EBITDA came in at 23.60 for Q2 2026, down 9.7% from 26.12 a year earlier but up 8.8% from the prior quarter.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) EV to EBITDA (2011 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EV to EBITDA at Vertex Pharmaceuticals was 19.57, down 9.2% year-over-year; for FY2025, it was 24.76.
- In prior years, Vertex Pharmaceuticals' EV to EBITDA was 23.33 in FY2023 (+63.9%), 14.24 in FY2022 (-14.4%) and 16.63 in FY2021 (-9.9%).
- Quarterly EV to EBITDA has run from a low of 14.24 in Q4 2022 to a high of 26.12 in Q2 2025 over five years.
- The strongest year-over-year quarter for EV to EBITDA in the past five years was Q4 2023, with growth of 63.9%; the weakest was Q3 2021, with a decline of 38.9%.
- According to Business Quant data, EV to EBITDA for the three prior quarters was 21.69 (Q1 2026), 24.76 (Q4 2025) and 22.22 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn |
| 10 | Vertex Pharmaceuticals | 126.70 Bn | 98.70 Bn | 2.84 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.60 |
| Mar 31, 2026 | 21.69 |
| Dec 31, 2025 | 24.76 |
| Sep 30, 2025 | 22.22 |
| Jun 30, 2025 | 26.12 |
| Mar 31, 2024 | 22.29 |
| Dec 31, 2023 | 23.33 |
| Sep 30, 2023 | 19.25 |
| Jun 30, 2023 | 19.29 |
| Mar 31, 2023 | 16.85 |
| Dec 31, 2022 | 14.24 |
| Sep 30, 2022 | 15.03 |
| Jun 30, 2022 | 14.91 |
| Mar 31, 2022 | 19.06 |
| Dec 31, 2021 | 16.63 |
| Sep 30, 2021 | 14.26 |
| Jun 30, 2021 | 19.10 |
| Mar 31, 2021 | 15.53 |
| Dec 31, 2020 | 18.47 |
| Sep 30, 2020 | 23.35 |
API Access
Vertex Pharmaceuticals EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();